MyMD Pharmaceuticals, Inc. (MYMD)

MyMD Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	4	13	45	228	18	2
Market Cap Growth	-94.03%	-70.99%	-80.10%	1193.72%	956.16%	-88.16%
Enterprise Value	3	8	41	217	22	-8
PE Ratio	-	-1.60	-2.99	-7.63	-1.86	-0.43
PB Ratio	0.43	1.07	3.09	9.65	-3.35	0.18
P/FCF Ratio	-0.37	-1.01	-3.70	-11.69	-3.78	-0.54
P/OCF Ratio	-0.37	-1.01	-3.70	-11.69	-3.78	-0.54
EV/EBITDA Ratio	-0.19	-2.07	-2.68	-7.25	-2.28	2.10
EV/EBIT Ratio	-0.19	-2.07	-2.68	-7.25	-2.28	2.06
EV/FCF Ratio	-0.22	-0.64	-3.32	-11.10	-4.63	2.61
Debt / Equity Ratio	0.00	0.00	0.01	0.01	-0.79	-
Debt / EBITDA Ratio	0.00	-0.01	-0.01	0.00	-0.44	-
Debt / FCF Ratio	0.00	0.00	-0.01	-0.01	-0.89	-
Quick Ratio	0.44	0.99	1.75	11.12	0.06	6.33
Current Ratio	0.62	1.17	1.95	12.18	0.06	6.74
Return on Equity (ROE)	-144.60%	-63.60%	-88.40%	-104.80%	-98.10%	-70.00%
Return on Assets (ROA)	-88.40%	-35.20%	-76.80%	-97.10%	-72.70%	-53.90%
Return on Capital (ROIC)	-173.63%	-131.74%	-103.01%	-118.51%	737.41%	-37.11%
Earnings Yield	-406.13%	-62.41%	-33.48%	-13.10%	-53.81%	-232.92%
FCF Yield	-252.73%	-98.58%	-27.03%	-8.56%	-26.45%	-183.78%
Buyback Yield / Dilution	-53.79%	-19.18%	-10.88%	-24.23%	-9101.99%	-25.81%
Total Shareholder Return	-53.79%	-19.18%	-10.88%	-24.23%	-9101.99%	-25.81%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).